Ottawa-Shanghai Joint School of Medicine


YING Xiaoying

Associate senior doctor


Tel: 18621517838

Research Fields: 肿瘤心脏病、心脏影像学、心脏康复


Dr. Ying received her medical degree from Shanghai Jiaotong University School of Medicine in 2003, and was later awarded a Master’s Degree in Medicine and a Medical Doctorate degree in 2005 and 2015, respectively. Dr. Ying then completed her postdoctoral training at Yale University School of Medicine in 2019.

Dr. Ying has over 17 years of clinical and research experience, she is skilled in the diagnosis and treatment of general cardiovascular diseases, including hypertension, hyperlipidemia, cardiac arrhythmias, coronary heart disease and chronic heart failure, ect. She has additional experience in sports cardiology, cardiac rehabilitation, and cardio-oncology. In addition to specializing in the treatment and diagnosis of cardiovascular disease, Dr. Ying has participated in several major research programs and has been published in well-known medical journals, including the Hypertension, the Antioxidants & Redox signaling,and the Cardiovascular Diabetology, etc. She has taken part in the writing and translation work of several books on cardiology.


  1. Ying X, Zhao Y, Yao T, Yuan A, Xu L, Gao L, Ding S, Ding H, Pu J, He B. Novel Protective Role for Ubiquitin-Specific Protease 18 in Pathological Cardiac Remodeling. Hypertension. 2016 Nov;68(5):1160-1170.

  2. Yao T#, Ying X#, Zhao Y, Yuan A, He Q, Tong H, Ding S, Liu J, Peng X, Gao E, Pu J, He B. Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulationof autophagy. Antioxid Redox Signal. 2015 Mar 10;22(8):633-50.

  3. He B, Zhao YC, Gao LC, Ying X, Xu LW, Su YY, Ji QQ, Lin N, Pu J. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Pathological Cardiac Hypertrophy. Hypertension. 2016 Jun;67(6):1237-48.

  4. He Q,Pu J,Yuan A,Yao T,Ying X,Zhao Y,Xu L,Tong H,He B,Liver X receptor agonist treatment attenuates cardiac dysfunction in type 2 diabetic db/db mice.,Cardiovascular Diabetology,2014,13(1):149-149.

  5. Tong H, Shan P, Zhao Y, Yuan A, He Q, Yao T, Ying X, Pu J, He B. Farnesoid-X-receptor blockade reduces myocardial reperfusion injury in cholesterol-fed apolipoprotein E knockout mice. Zhonghua Xin Xue Guan Bing Za Zhi. 2013 Aug; 41(8):642-646.

  6. Xu J, Chen Y, Li H, Ying X, Song X, He B. Successful ablation on a patient with left Mahaim fiber mediated atrioventricular reentrant tachycardia. Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Aug; 39(8):764.

  7. Chen Y, Xu J, Li H, Ying X, Song W, Ding H, Xie X, Wang B, He B. Clinical significance of serum sCD40L changes in patients with different types of coronary heart diseases. Chinese Heart Journal. 2008, 20(2):213-215.

  8. Ying X, Wang C, Li J, Zhang Q, Xie X, Xu Y, Ding H, He B. Relationship between Insulin-like Growth Factor I and Severity of Coronary Artery Disease. Journal of Shanghai Jiaotong University (Medical Science). 2006,26(3):244-248

  9. Wang C, Zang M, Ying X. Diagnosis and Treatment of Ventricular arrhythmia. New Chinese Medicine. 2006, 37(5):333-335.

  10. Ying X, Wang C, He B. Relationship between insulin-like growth factor I and metabolic syndrome. Chinese Heart Journal.2006, 18(5):496-498.

  11. Ying X, Wang C. PAPP-A and atherosclerosis. Foreign Medical Sciences (Section Of Pathophysiology And Clinical Medicine) 2005, 25(2):114-117.